Techno Medica Co., Ltd.

Tokyo Stock Exchange 6678.T

Techno Medica Co., Ltd. Receivables for the year ending March 31, 2024: USD 0.00

Techno Medica Co., Ltd. Receivables is USD 0.00 for the year ending March 31, 2024, a -100.00% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Techno Medica Co., Ltd. Receivables for the year ending March 31, 2023 was USD 27.53 M, a -8.23% change year over year.
Techno Medica Co., Ltd. Receivables for the year ending March 31, 2022 was USD 30.00 M, a -7.84% change year over year.
Techno Medica Co., Ltd. Receivables for the year ending March 31, 2021 was USD 32.55 M, a 5.44% change year over year.
Techno Medica Co., Ltd. Receivables for the year ending March 31, 2020 was USD 30.87 M, a 6.01% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Tokyo Stock Exchange: 6678.T

Techno Medica Co., Ltd.

CEO	Mr. Masatomo Saneyoshi
IPO Date	March 12, 2007
Location	Japan
Headquarters	5-5-1, Nakamachidai
Employees	237
Sector	Health Care
Industries Medical Instruments Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.

Key trends

Past 5 years